Loading clinical trials...
Loading clinical trials...
The overall goal of the study is to investigate the functional, biochemical, and gene expression effects of Interferon-gamma 1-b (IFN-γ) on the neutrophils of patients with Chronic Granulomatous Disea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
NCT05189925 · Chronic Granulomatous Disease, Infection
NCT03645486 · Chronic Granulomatous Disease
NCT05463133 · Chronic Granulomatous Disease
NCT06605378 · Chronic Granulomatous Disease (CGD)
NCT07284641 · Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder, and more
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions